Results 191 to 200 of about 80,222 (255)

Increased Endurance of Nonvolatile Photonics Enabled by Nanostructured Phase‐Change Materials

open access: yesAdvanced Materials, Volume 38, Issue 31, 2 June 2026.
Tapered and segmented islands of the phase‐change material (PCM) antimony selenide (Sb2Se3) integrated on silicon microring resonators enable ultra‐low‐loss, high‐endurance, non‐volatile photonic tuning. The nanostructured PCM design suppresses interfacial scattering and thermal stress, achieving record endurance over 100 million electrical switching ...
Jayita Dutta   +10 more
wiley   +1 more source

The Emerging Parkinson's Disease Oxylipin‐Ome

open access: yesAdvanced Science, Volume 13, Issue 33, 15 June 2026.
ABSTRACT Parkinson Disease (PD) is increasingly considered a proteinopathy and lipidopathy. This proteinopathy+lipidopathy paradigm has been further refined to a fatty acid (FA)‐opathy, centering dysregulated FA metabolism as fundamental in PD lipid dysfunction.
Julia C. Kelliher, Saranna Fanning
wiley   +1 more source

Early and Larval Development of the Marine Species Grey Triggerfish (Balistes capriscus, Gmelin, 1789) and the Use of Different Organisms as First Food Sources

open access: yesAquaculture, Fish and Fisheries, Volume 6, Issue 3, June 2026.
ABSTRACT The aim of this study was to provide an initial description of the embryology and larval development of Balistes capriscus species obtained from natural spawning in captivity. The study also aimed to assess the stocking density and the impact of offering four types of live food as the initial feed during the larviculture phase. Observations of
Henrique David Lavander   +9 more
wiley   +1 more source

Prediction of cognitive outcome and progression to dementia using ω6‐PUFA/ω3‐PUFA ratio

open access: yesAlzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION The polyunsaturated fatty acids (PUFAs) omega‐6 (ω6) and omega‐3 (ω3) are linked to cognitive performance and Alzheimer's‐type dementia (DAT), but ω3‐PUFA supplementation offers limited benefits. We propose that the ω6‐PUFA/ω3‐PUFA ratio better explains cognitive decline and DAT risk.
Víctor Andrade   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy